Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Financial Flexibility Index
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of $137.91K (operating CF $137.91K minus capex $4.00) represents 0% of total liabilities ($7.36 Million). Explore Drugs Made In America Acquisition Corp. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Drugs Made In America Acquisition Corp. Ordinary Shares Financial Flexibility Index (2024–2024)
Historical Financial Flexibility Index trend for Drugs Made In America Acquisition Corp. Ordinary Shares across 1 annual periods. See DMAA net asset quality index to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Drugs Made In America Acquisition Corp. Ordinary Shares (2024–2024)
Year-by-year free cash flow to debt coverage for Drugs Made In America Acquisition Corp. Ordinary Shares. For the full company profile including market capitalisation, see DMAA company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -216.50x | $-172.26K | $-172.26K | $795.67 | — |